AURYXIA (ferric citrate) Keryx biopharms Patent: 8,093,423 Expiration: Apr 21, 2026 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of April 19, 2026 Read Post »
When Johnson & Johnson’s multiple myeloma franchise Darzalex (daratumumab) generated roughly $10 billion in global revenue in 2024, it stood
We rarely know where our medicines originate. The global pharmaceutical supply chain is an opaque network of chemical synthesis facilities,
Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data Read Post »
TAVALISSE (fostamatinib disodium) Rigel pharms Patent: 7,538,108 Expiration: Mar 28, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of March 22, 2026 Read Post »
1. Why Patent Expiry Forecasting Is a Revenue-Critical Discipline ‘Between 2025 and 2030, approximately 190 drugs will lose market exclusivity,
1. The $2.8 Trillion Arithmetic: Market Structure and Strategic Stakes The global pharmaceutical market reached approximately $1.6 trillion in 2024
A deep dive covering the ANDA pathway, EU MAA procedures, bioequivalence science, Paragraph IV litigation strategy, patent cliff analysis, evergreening
The $236 Billion Race Most Procurement Teams Are Losing Between 2025 and 2030, more than $236 billion in branded pharmaceutical
I. Market Context: Why the CDMO Sector Is Repricing The global pharmaceutical CDMO market hit approximately $181.93 billion in 2025,
Get fresh news and insights, drug patent expirations & more…
